UCSF HELEN DILLER FAMILY COMPREHENSIVE CANCER CENTER
kmUU300MXic
kmUU300MXic
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Presentations<br />
Impact of age and comorbidity on treatment of non-small cell lung<br />
cancer (NSCLC) recurrence (AFT-03).<br />
Authors*: Melisa L. Wong, Timothy L. McMurry, George J. Stukenborg, Amanda B. Francescatti,<br />
Jessica R. Schumacher, Louise C. Walter, Benjamin D. Kozower<br />
Abstract #: 10037<br />
Presentation Date/Time: Monday, June 6: 1:00 - 4:30 PM<br />
Location: Hall A, Poster Board #25<br />
Poster Session: Patient and Survivor Care<br />
Citation: J Clin Oncol 34, 2016 (suppl; abstr 10037)<br />
Walter Research Interests: Dr. Walter is a clinician-researcher who is a national leader in evaluating the<br />
real-world risks and benefits of cancer screening in older patients. Dr. Walter joined the <strong>UCSF</strong> faculty<br />
in July 2001, and she is a geriatrician at the San Francisco VA Medical Center. She has developed novel<br />
methodology demonstrating the fundamental importance of life expectancy rather than age in determining<br />
benefits and risks of screening. Virtually every cancer screening guideline cites her research. In addition,<br />
Dr. Walter led a series of seminal studies demonstrating decisions to screen older adults for cancer are often<br />
dictated more by age than health such that many patients in poor health continue to undergo screening<br />
while many healthy older patients fail to get screened. Also, she discovered that cancer screening frequently<br />
leads to significant harms without benefit in patients in poor health and developed a taxonomy and<br />
quantification of screening harms.<br />
http://cancer.ucsf.edu/people/profiles/walter_louise.3728<br />
*<strong>UCSF</strong> authors in bold<br />
80
Change language